Intismeran autogene: clinical trials recruiting now

4

Recruiting trials

6

Conditions studied

35

US states with sites

43

Countries

Phase breakdown

Phase 2 2 Phase 3 2

Conditions being studied

Condition	Trials
Lung cancer · Intismeran autogene for Lung cancer	3
Carcinoma, Non-Small-Cell Lung	1
Malignant Melanoma	1
Melanoma	1
Non-small Cell Lung Cancer	1
Squamous Non-small Cell Lung Cancer	1

Recruiting trials involving Intismeran autogene

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
NCT06961006 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 38 locations
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
NCT06077760 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 229 locations
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
NCT07221474 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 55 locations
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
NCT06623422 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 241 locations

Common questions

How many recruiting trials involve Intismeran autogene?

4 recruiting trials across 6 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.